Compare Heron Therapeutics Inc (HRTX) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Okta, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Okta, Inc. trades at $151.56 (market cap $26.13B). The key difference: Okta, Inc. is far larger — about 425.1× Heron Therapeutics Inc's market cap, and Okta, Inc. is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | OKTA | |
|---|---|---|
Market Cap | $61.47M | $26.13B |
Sector | Health | Technology |
52-Week High | $1.49 | $154.62 |
52-Week Low | $0.32 | $62.93 |
Enterprise Value | $168.21M | $23.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
